1. 5′-deoxy-5-fluorouridine—a new orally active antitumor agent;Kramer,1979
2. Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridine;Bollag;Eur J Cancer,1980
3. Phase I study of oral doxifluridine using two schedules;Alberto;Eur J Cancer Clin Oncol,1989
4. Selective activation of 5′-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index;Armstrong;Cancer Res,1981
5. Phase I clinical study with 5′-deoxy-5-fluorouridine, a new fluropyrimidine derivative;Abele;Cancer Treat Rep,1982